Please ensure Javascript is enabled for purposes of website accessibility

Why Eastman Kodak Shares Plunged 73% Lower Last Month

By Anders Bylund - Sep 7, 2020 at 1:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The game-changing government contract that drove Kodak's shares higher in July might be a mirage after all.

What happened

Shares of Eastman Kodak (KODK 3.28%) fell 72.6% lower in August 2020, according to data from S&P Global Market Intelligence. If you stretch the timeline out by a few days in each direction, Kodak's stock has plunged 81.6% lower since the multi-year highs of July 29.

^SPX Chart

^SPX data by YCharts

So what

The stock skyrocketed near the end of July due to a $765 million government contract for which Kodak was asked to produce generic ingredients for pharmaceutical drugs. The excitement faded quickly in August as the drug-ingredients deal was put on hold due to allegations of shady details behind the agreement. Several executives received stock options the day before the deal was announced and share prices surged, and Kodak may have influenced the government's choice of ingredient suppliers through overly generous lobbyist donations from the company to key lawmakers.

Kodak's disappointing second-quarter report on August 11 didn't do any favors for the stock, either.

A rocket crashing into the sound block of a wooden gavel.

Image source: Getty Images.

Now what

Kodak's potentially game-changing deal is now under investigation by the Securities and Exchange Commission. Whether or not the contract survives this legal challenge and further investigations, Kodak strikes me as a risky investment with a background of bankruptcy and low-quality corporate governance policies. I wouldn't touch this household name's penny stock with a ten-foot pole no matter what happens to the large pharmaceutical-ingredients deal.



Anders Bylund has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Eastman Kodak Stock Quote
Eastman Kodak
KODK
$6.92 (3.28%) $0.22

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.